Ana Valeria Meléndez Mayorga
Has participated in:
-
Lectin-based tools for cancer immunotherapy targeting the glycosphingolipid Gb3
-
A bispecific, crosslinking lectibody activates cytotoxic T cells and induces cancer cell death
-
A Shiga toxin B-subunit-based lectibody boosts T cell cytotoxicity towards Gb3-positive cancer cells
-
Dimeric lectin chimeras as novel candidates for gb3-mediated transcytotic drug delivery through cellular barriers